依维莫司用于晚期肾细胞癌的二线治疗NICE2011.pdfVIP

Issue date: April 2011 Everolimus for the second-line treatment of advanced renal cell carcinoma This guidance was developed using the single technology appraisal process NICE technology appraisal guidance 219 NICE technology appraisal guidance 219 Everolimus for the second-line treatment